Skip to main content

U.S. Apheresis Equipment (Disposable Kits, Device, Renal Disease, Neurology) Market Size, Share & Trends Analysis Report 2024-2030 - ResearchAndMarkets.com

The "U.S. Apheresis Equipment Market Size, Share & Trends Analysis Report by Product (Disposable Apheresis Kits, Device), Application (Renal Disease, Neurology), Procedure, Technology, and Segment Forecasts, 2024-2030" report has been added to ResearchAndMarkets.com's offering.

The U.S. apheresis equipment market size is anticipated to reach USD 1.64 billion by 2030, expanding at a CAGR of 8.6% from 2024 to 2030

Continuous improvements in apheresis technology have led to the development of more efficient, user-friendly, and cost-effective equipment. The rise in the prevalence of chronic diseases in the U.S., such as kidney failure, cancer, and autoimmune disorders, has led to a higher demand for apheresis procedures. For instance, according to the National Library of Medicine, in 2023, approximately 1,958,310 new cancer cases were observed in the U.S., that in turn, drives the need for apheresis equipment.

New product launches in the U.S. market bring innovative features and technological advancements to the equipment, improving their efficiency, accuracy, and performance. Regulatory approvals ensure that the apheresis equipment meets safety and efficacy standards, which is crucial for the end-users, such as hospitals and clinics. For instance, according to the Association for the Advancement of Blood & Biotherapies, in August 2023, Terumo BCT received its FDA clearance for its Reveous Automated Whole Blood Processing System. This boosts consumer confidence and contributes to the growth of the market.

U.S. Apheresis Equipment Market Report Highlights

  • Based on product, disposable apheresis kits dominated the market with more than 70% share in 2023 owing to the feature of eliminating the risk of cross-contamination and infection transmission between patients, as each kit is used only once and then discarded
  • The device segment is expected to grow at the fastest CAGR over the forecast period
  • Based on application, the neurology segment held the largest market share in 2023. Apheresis helps to remove the disease-causing antibodies or immune cells, thus reducing inflammation and protecting the nerves
  • Market players operating in the U.S. apheresis equipment market include Haemonetics Corporation, Fresenius Kabi, B. Braun SE, Mallinckrodt Pharmaceuticals

Companies Featured

  • Haemonetics Corporation
  • Fresenius Kabi
  • B. Braun SE
  • Mallinckrodt Pharmaceuticals
  • Nikkiso Co., Ltd.
  • Asahi Kasei Medical Co., Ltd.
  • Terumo BCT

Key Attributes:

Report Attribute Details
No. of Pages 80
Forecast Period 2023 - 2030
Estimated Market Value (USD) in 2023 $917.9 Million
Forecasted Market Value (USD) by 2030 $1640 Million
Compound Annual Growth Rate 8.6%
Regions Covered United States

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.3. Competitive Insights

Chapter 3. U.S. Apheresis Equipment Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent Market Outlook

3.1.2. Related/ancillary Market Outlook

3.2. Market Dynamics

3.2.1. Market Driver Analysis

3.2.2. Market Restraint Analysis

3.3. U.S. Apheresis Equipment Market Analysis Tools

3.3.1. Industry Analysis - Porter's

3.3.2. PESTEL Analysis

Chapter 4. U.S. Apheresis Equipment Market: Product Estimates & Trend Analysis

4.1. Product Market Share, 2023 & 2030

4.2. Segment Dashboard

4.3. U.S. Apheresis Equipment Market by Product Outlook

4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030

4.4.1. Disposable Apheresis Kits

4.4.2. Device

Chapter 5. U.S. Apheresis Equipment Market: Application Estimates & Trend Analysis

5.1. Application Market Share, 2023 & 2030

5.2. Segment Dashboard

5.3. U.S. Apheresis Equipment Market by Application Outlook

5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030

5.4.1. Renal Disease

5.4.2. Neurology

5.4.3. Hematology

Chapter 6. U.S. Apheresis Equipment Market: Procedure Estimates & Trend Analysis

6.1. Procedure Market Share, 2023 & 2030

6.2. Segment Dashboard

6.3. U.S. Apheresis Equipment Market by Procedure Outlook

6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030

6.4.1. Photopheresis

6.4.2. Plasmapheresis

6.4.3. LDL Apheresis

6.4.4. Plateletpheresis

6.4.5. Leukapheresis

6.4.6. Erythrocytapheresis

Chapter 7. U.S. Apheresis Equipment Market: Technology Estimates & Trend Analysis

7.1. Technology Market Share, 2023 & 2030

7.2. Segment Dashboard

7.3. U.S. Apheresis Equipment Market by Technology Outlook

7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030

7.4.1. Membrane Filtration

7.4.2. Centrifugation

Chapter 8. U.S. Apheresis Equipment Market: Region Estimates & Trend Analysis

8.1. Regional Market Share, 2023 & 2030

8.2. U.S. Apheresis Equipment Market by Region Outlook

8.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030

8.3.1. West

8.3.2. Midwest

8.3.3. Northeast

8.3.4. Southwest

8.3.5. Southeast

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, by Key Market Participants

9.2. Company/Competition Categorization

9.3. Vendor Landscape

9.3.1. List of Key Distributors and Channel Partners

9.3.2. Key Customers

9.3.3. Key Company Heat Map Analysis, 2023

9.4. Company Profiles

9.4.1. Company Overview

9.4.2. Financial Performance

9.4.3. Product Benchmarking

9.4.4. Strategic Initiatives

For more information about this report visit https://www.researchandmarkets.com/r/8txmo2

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.